Skip to content
Press Releases
Filter Releases
 
Press Releases
Oct 22, 2012
South San Francisco, Calif. --- October 22, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that study findings demonstrating the analytic validity of its Afirma® Gene Expression Classifier have been published online in the ...
PDF
Aug 29, 2012
South San Francisco, Calif. and Cambridge, Mass. --- August 29, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced that the New York Sta...
PDF
Jul 17, 2012
South San Francisco, Calif. and Cambridge, Mass. — July 17, 2012 — Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, and Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), today announced the publica...
PDF
Jun 25, 2012
Houston, Texas — June 25, 2012 — Veracyte, Inc., a molecular diagnostics company that is pioneering the emerging field of molecular cytology, today announced results from a large, prospective, multicenter study, which demonstrated the potential for the Afirma® Gene Exp...
PDF
Apr 16, 2012
Cambridge, Mass. and South San Francisco, Calif. --- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY), and Veracyte, Inc., a molecular diagnos...
PDF
Apr 5, 2012
South San Francisco, Calif. --- April 5, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced the appointment of Richard T. Kloos, MD, as Senior Medical Director. In this role, Dr. Kloos will educate the endocrinology community about ...
PDF
Jan 20, 2012
Cambridge, Mass. and South San Francisco, Calif. --- January 20, 2012 --- Genzyme, a Sanofi company (EURONEXT: SAN and NYSE: SNY) and one of the world’s leading biotechnology companies, and Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today anno...
PDF
Jan 9, 2012
South San Francisco, Calif. --- January 9, 2012 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that Palmetto GBA, a national contractor that administers Medicare benefits, has established coverage for the company’s Afirma® Gene Expression Classifier f...
PDF
Sep 1, 2011
South San Francisco, Calif. --- September 1, 2011 --- Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, today announced that new data from researchers at Johns Hopkins University School of Medicine suggest that routine use of its Afirma® Gene Expression Classifier for clarifyin...
PDF
Sep 15, 2010
South San Francisco, Calif.--- PRNewswire ---Veracyte, Inc., a molecular diagnostics company pioneering the emerging field of molecular cytology, announced that initial data from its large-scale, prospective, multi-center clinical trial were presented today at the 14th International Thyroid Congress, held in Paris, France. The findings showed th...
PDF
Page: First Previous
...
Next Last